Medical Marijuana Archives

08Apr

Acquisition-Side Due Diligence in The Legal Cannabis Industry: Approach and Expectations for Both Sides

By Greg Chin, Kevin Michaelan and Jeffrey Michelson, Partner Continuing with the topic of industry trends from our last post, we explore the art of acquisition-side due diligence from full-scope financial and tax to limited-scope tax-only engagements. We’ll look at what to expect and how to approach it. Although commonly geared toward the investor/acquirer, i.e., […]

26Mar

Medical Cannabis, Texas-Style: Conditions and Requirements for Use

Marijuana Insights

Leave a comment

By Ashley Simpson, Hoban Law Group In 2015, the Texas legislature’s passage of the Texas Compassionate Use Act (Senate Bill 339) legalized medical cannabis in the Lone Star State, but only to the extent of "low-THC cannabis oil" for use by patients diagnosed with intractable epilepsy. Widening further access to any patients respectively diagnosed with […]

25Mar

Planning for the Coming Consolidation in the Cannabis Industry

Marijuana Insights

Leave a comment

By Michael Harlow, CPA, Partner In today’s Cannabis marketplace, we continue to hear one overarching theme. The industry buzz on everyone’s lips is about “the future consolidation of the industry. This is driven by several factors: strong customer and revenue growth for retailers, price compression for wholesalers, an expected change in the legal landscape, new […]

25Mar

The Impact of Regulations on Price

Marijuana Insights

Leave a comment

By Yona Torres, New Frontier Data Contributing Editor In the 16 months since California legalized marijuana, cannabis prices in some California market sectors have plummeted 75%, according to the Washington Post. This steep decline, paralleled in Colorado, Oregon and Washington, is a product of the number of newly-licensed cultivators and the regulations that guide them. […]

24Mar

America’s Wounded Veterans Need and Want Medical Cannabis; It is Time the Federal Government Provides It

Marijuana Insights

Leave a comment

By Joseph Romm, Ph.D. What We Have Learned: Given the potential for medicinal cannabis in the treatment of chronic pain, opioids addiction, and other conditions plaguing veterans, it is time for the federal government to afford them access to it. July 30, 2017 -- Scientific evidence is growing that medical cannabis may provide some promising […]

24Mar

Five Components to Look for Out of California and Cannabis Markets at Large

Marijuana Insights

Leave a comment

By J.J. McCoy, Senior Managing Editor for New Frontier Data What We Have Learned: Figuring where California’s example and output will lead the world can make the proverbial $64,000 question seem like a rounding error. August 27, 2017 -- New Frontier Data constantly examines various dimensions of the industry to identify, quantify and holistically discern its […]

23Mar

On-Demand Services Become Vital Within the Maturing Retail Marketplace

Marijuana Insights

Leave a comment

By J.J. McCoy, Senior Managing Editor for New Frontier Data What We Have Learned: As the cannabis industry grows ever larger and more competitive, the ability to identify the “who”, “what”, and “when” in purchasing habits will be imperative to retailers, and essential for one’s overall enterprise. (Sept.3, 2017) -- With the advent of California’s adult […]

23Mar

Business Challenges Intensify Amid Falling Prices in California

Marijuana Insights

Leave a comment

By J.J. McCoy, Senior Managing Editor for New Frontier Data What We Have Learned: Falling prices in the expanded California markets will drive operators to focus on performance efficiency and cost savings even while trying to establish branding and consumer engagement. (Sept. 10, 2017) -- As the burgeoning cannabis market has started to mature in markets […]

23Mar

Cannabis Investors Would Do Well to Keep These Three Tenets in Mind

Marijuana Insights

Leave a comment

Mitch Baruchowitz, Managing Partner at Merida Capital Partners What We Have Learned: Focus on adoption and make sure that investments have crossed the “fragmentation gap”, find management teams who have direct experience with the types of challenges they will face in their cannabis enterprise, and look for companies that serve large addressable markets that naturally […]

23Mar

An Rx for Returns: Medical Markets Remain Sound for Investment in 2018

Marijuana Insights

Leave a comment

By New Frontier Data staff analysts What We Have Learned: With an annual GDP that would rank by itself as the world’s sixth-largest national economy, California will best the top three U.S. medical cannabis markets by revenue in 2018. Oct. 1, 2017: Next month will mark a year since millions of Americans successfully voted to […]